FCP
Fidelis Capital Partners Portfolio holdings
AUM
$1.1B
This Quarter Return
+5.76%
1 Year Return
+20.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$840M
AUM Growth
+$840M
(+20%)
Cap. Flow
+$65.6M
Cap. Flow
% of AUM
7.81%
Top 10 Holdings %
Top 10 Hldgs %
34.26%
Holding
429
New
51
Increased
222
Reduced
108
Closed
18
Top Buys
| 1 |
iShares Russell Top 200 Growth ETF
IWY
|
$4.54M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$4.21M |
| 3 |
Apple
AAPL
|
$3.37M |
| 4 |
Vanguard Russell 1000 Value ETF
VONV
|
$2.8M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$2.43M |
Top Sells
| 1 |
Visa
V
|
$966K |
| 2 |
Eli Lilly
LLY
|
$767K |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
$666K |
| 4 |
Valaris
VAL
|
$637K |
| 5 |
CVS Health
CVS
|
$635K |
Sector Composition
| 1 | Technology | 22.64% |
| 2 | Financials | 7.56% |
| 3 | Consumer Discretionary | 6.51% |
| 4 | Healthcare | 6.29% |
| 5 | Communication Services | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
426
Valaris
VAL
$3.5B
| – | – |
-10,132
| Closed | -$637K |
|
|
EVA
427
DELISTED
Enviva Inc.
EVA
| – | – |
-25,163
| Closed | -$10.9K |
|
|
EGRX
428
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| – | – |
-12,762
| Closed | -$54.2K |
|